Skip to main content
Equibles
DVA logo

DVA · Davita Inc. · Metrics

Track DVA — free

Use DVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$184.03 +0.39 (+0.21%) At close · Oct 26
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.74B
Shares
63.80M
Volume · Oct 26 570.69K Avg daily vol (3M) 784.43K

DVA metrics

101 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$184.03
Market cap
$11.74B

Price action

20 metrics
Price change (1W)
-1.6%
Price change (30D)
+3.3%
Price change (3M)
-22.1%
Price change (6M)
+22.6%
Price change (YTD)
+62.0%
Price change (1Y)
+42.4%
Trailing year
Price change (5Y)
+64.2%
52-week high
$240.96
52-week low
$103.87
Change from 52-week high
-23.6%
Change from 52-week low
+77.2%
Annualized volatility
46.6%
Annualized volatility (3M)
47.3%
Beta
-0.1
RSI (14D)
52.2
Price vs SMA 50
+1.9%
Price vs SMA 200
+4.9%
Avg volume (3M)
784,430
Relative volume
0.7
Average dollar volume
$147.69M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
63.80M

Valuation

12 metrics
P / E (TTM)
15.1
Trailing earnings · reciprocal yield 6.6%
PEG ratio
0.3
EV / revenue
1.6×
reciprocal yield 64.2%
EV / EBITDA
7.7×
reciprocal yield 13.0%
EV / EBIT
10.3×
reciprocal yield 9.7%
P / sales
0.8×
reciprocal yield 119.3%
P / book
—
FCF yield
13.7%
TTM · current market cap
Buyback yield
7.6%
P / FCF
7.3
reciprocal yield 13.7%
P / operating cash flow
5.4
reciprocal yield 18.7%
Earnings yield
7.2%

Historical valuation

8 metrics
P / E historical average (3Y)
15.5×
reciprocal yield 6.5%
P / E historical average (5Y)
14.4×
reciprocal yield 7.0%
EV / revenue historical average (3Y)
1.6×
reciprocal yield 64.3%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 65.3%
EV / EBIT historical average (3Y)
10.5×
reciprocal yield 9.5%
EV / EBIT historical average (5Y)
10.9×
reciprocal yield 9.2%
EV / EBITDA historical average (3Y)
7.6×
reciprocal yield 13.2%
EV / EBITDA historical average (5Y)
7.7×
reciprocal yield 13.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
7.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
15.2%
Trailing 12 months
Net margin
6.0%
Gross profit (TTM)
—
Operating profit (TTM)
$2.13B
Net income (TTM)
$847.48M
Trailing 12 months
Diluted EPS (TTM)
$12.15
FCF margin
11.5%
Effective tax rate
20.7%

Per share

11 metrics
Revenue per diluted share (TTM)
$200.52
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$30.49
EBITDA per diluted share (TTM)
$40.53
Net income per diluted share (TTM)
$12.21
Operating cash flow per diluted share (TTM)
$31.07
Free cash flow per diluted share (TTM)
$22.73
Capital expenditures per diluted share (TTM)
$8.34
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.87
Book value per share
$-9.50

Growth

11 metrics
Revenue growth YoY
+5.2%
Year over year
Net income growth YoY
+33.1%
Revenue (TTM)
$14.01B
Trailing 12 months
EPS growth YoY
+55.8%
Shares change YoY
-14.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.5%
Revenue CAGR (5Y)
+3.4%
EPS CAGR (3Y)
+18.9%
EPS CAGR (5Y)
+9.3%
FCF CAGR (3Y)
+10.9%
FCF CAGR (5Y)
+0.1%

Quality

14 metrics
Return on equity
—
Return on assets
4.8%
Debt / equity
—
Current ratio
1.5
EBITDA (TTM)
$2.83B
Free cash flow (TTM)
$1.61B
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
3.6
Return on invested capital
18.1%
Trailing 12 months
Net cash
−$10.09B
Latest balance sheet
Cash & equivalents
$668.96M
Total assets
$17.71B
Total debt
$10.78B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.19B
Capital expenditures (TTM)
$583.35M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$131.57M
R&D / revenue
—
Stock compensation / revenue
0.9%

Ownership (13F)

9 metrics
13F filers
639
13F filer change QoQ
+53
Institutional ownership
96.1%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
12.9%
Private-fund adviser ownership
11.1%
Active holders' share change QoQ
-5.5%
Holder tenure
21.9
Price vs estimated holder cost
+50.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.7%

Short interest

3 metrics
Short interest
7.7%
Latest settlement · 9.7 days to cover
Days to cover
9.7d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 927066 CUSIP 23918K108 13F (30d) 131 filings 127 filers Visit website Investor relations